Natera Inc (NTRA) - Total Liabilities
Based on the latest financial reports, Natera Inc (NTRA) has total liabilities worth $840.38 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Natera Inc - Total Liabilities Trend (2012–2025)
This chart illustrates how Natera Inc's total liabilities have evolved over time, based on quarterly financial data. See NTRA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Natera Inc Competitors by Total Liabilities
The table below lists competitors of Natera Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bank of Communications Co. Ltd
F:C4C
|
Germany | €14.97 Trillion |
|
Las Vegas Sands Corp
NYSE:LVS
|
USA | $19.99 Billion |
|
Daimler Truck Holding AG
F:DTG
|
Germany | €52.20 Billion |
|
DAIMLER TRUCK SP.ADS/1/2
F:DTG1
|
Germany | €52.20 Billion |
|
Bajaj Finserv Limited
NSE:BAJAJFINSV
|
India | Rs6.15 Trillion |
|
Gree Electric Appliances Inc of Zhuhai
SHE:000651
|
China | CN¥250.71 Billion |
|
PTT Public Company Limited
BK:PTT
|
Thailand | ฿1.62 Trillion |
|
Ameren Corp
NYSE:AEE
|
USA | $36.16 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Natera Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NTRA company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Natera Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Natera Inc (2012–2025)
The table below shows the annual total liabilities of Natera Inc from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $795.62 Million | +70.99% |
| 2024-12-31 | $465.31 Million | -31.20% |
| 2023-12-31 | $676.37 Million | -1.79% |
| 2022-12-31 | $688.73 Million | +18.10% |
| 2021-12-31 | $583.18 Million | +30.78% |
| 2020-12-31 | $445.92 Million | +46.71% |
| 2019-12-31 | $303.94 Million | +28.79% |
| 2018-12-31 | $236.01 Million | +24.74% |
| 2017-12-31 | $189.20 Million | +81.56% |
| 2016-12-31 | $104.20 Million | +29.49% |
| 2015-12-31 | $80.47 Million | -72.72% |
| 2014-12-31 | $294.96 Million | +27.56% |
| 2013-12-31 | $231.23 Million | +66.47% |
| 2012-12-31 | $138.90 Million | -- |
About Natera Inc
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehe… Read more